Pharmacokinetic study of copper (II) acetylsalicylate

Biological Trace Element Research

Volumn 124, Issue 3, 2008, Pages 283-288

  Iqbal, Mohammad S ^a   Sher, Muhammad ^b,c   Pervez, Humayun ^c   Saeed, Maryiam ^d  

^a GC UNIVERSITY   (Pakistan)

^b UNIVERSITY OF SARGODHA   (Pakistan)

^c BAHAUDDIN ZAKARIYA UNIVERSITY   (Pakistan)

^d ALLAMA IQBAL MEDICAL COLLEGE   (Pakistan)

Author keywords

Biodistribution; Copper; Copper acetylsalicylate; Copper aspirinate; Pharmacokinetics

Indexed keywords

ACETYLSALICYLATE COPPER; ACETYLSALICYLIC ACID; SALICYLIC ACID; COPPER SALICYLATE COMPLEX; DRUG DERIVATIVE; ORGANOMETALLIC COMPOUND; SALICYLIC ACID DERIVATIVE; TETRAKIS MU ACETYLSALICYLATO DICOPPER(II); TETRAKIS-MU-ACETYLSALICYLATO-DICOPPER(II); UNCLASSIFIED DRUG;

ADULT; ANTIINFLAMMATORY ACTIVITY; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG TOLERANCE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; MALE; MAXIMUM PLASMA CONCENTRATION; NAUSEA; NORMAL HUMAN; PHARMACOKINETICS; PLASMA CONCENTRATION-TIME CURVE; TIME TO MAXIMUM PLASMA CONCENTRATION; ADOLESCENT; BLOOD; CLINICAL TRIAL; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ASPIRIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HUMANS; MALE; ORGANOMETALLIC COMPOUNDS; SALICYLATES; YOUNG ADULT;

EID: 58149381088     PISSN: 01634984     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12011-008-8146-3     Document Type: Article

References (15)

1. DY Graham JL Smith 1986 Aspirin and the stomach Ann Intern Med 104 3 390 398 (Pubitemid 16163622)
2. PJ Roderick HC Wilkes TW Meade 1993 The gastrointestinal toxicity of aspirin: an overview of randomised controlled trials Br J Clin Pharmacol 35 3 219 226 (Pubitemid 23074044)
3. JRJ Sorenson 1976 Copper chelates as possible active forms of the antiarthritic agents J Med Chem 19 1 135 148
4. JRJ Sorenson 1978 Copper complexes-a unique class of antiarthritic drugs Prog Med Chem 15 211 60 review
5. Medical News 1974 Copper boost activity of anti-inflammatory drugs JAMA 229 1268 1269
6. S Malkiel R Har-el H Schwalb G Uretzky JB Borman M Chenion 1993 Free Radic Res Commun 18 1 7 15
7. I Mazzetti B Grigolo RM Borzi R Meliconi A Facchini 1996 Int J Clin Lab Res 26 4 245 249
8. LB Tyrer 1984 Nutrition and the pill J Reprod Med 29 7 Suppl 547 550 (Pubitemid 14061772)
9. Sorenson JRJ (1982) Inflammatory diseases and copper. Humana, Clifton, NJ
10. LL Borer E Barry 2000 Experiments with aspirin J Chem Educ 77 354
11. P Vinod K Kamal WA John M Howard D James J Iain N Rabindra L Mark T Alfred CT Viswanathan Y Avraham 2000 Bioanalytical method validation-a revisit with a decade of progress Pharm Res 17 12 1551 1557 (Pubitemid 32217566)
12. JN Buskin RA Upton RL Williams 1982 Improved liquid chromatography of aspirin, salicylate, and salicyluric acid in plasma, with a modification for determining aspirin metabolites in urine Clin Chem 28 5 1200 1203
13. CB Elliot RL Lesley B Felix MI Debra 1980 Measurement and pharmacokinetics of acetylsalicylic acid by a novel high performance liquid chromatographic assay Ther Drug Monit 2 4 365 372 (Pubitemid 11142018)
14. Schwartz S, Paterman T. Pre-clinical pharmacokinetics. In: The comprehensive resource for physicians, drug and illness information. Available at: http://www.rxmed.com/b.main/b2.pharmaceutical/b2.1.monographs/CPS- %20Monographs/CPS-%20(General%20Monographs-%20A)/ASPIRIN.html
15. G Levy 1978 Clinical pharmacokinetics of aspirin Pediatrics 62 5 867 (Pubitemid 9009957)